Statistics from Altmetric.com
Q Is sustained-release bupropion, sertraline, or extended-release venlafaxine effective for people with major depressive disorder in whom citalopram is not effective?
Randomised controlled trial.
Follow up period:
Eighteen primary and 23 psychiatric public and private practices, USA. Enrolled: July 2001 to August 2004.
727 people with non-psychotic major depressive disorder who were intolerant of citalopram or in whom citalopram did not produce remission (failure to remit: Quick Inventory of Depressive Symptomatology-Clinician Rated (QIDS-C-16) score >5). Inclusion criteria were described as being broad with limited exclusions. Detailed exclusion criteria included: concomitant antidepressants outside of the protocol, mood stabilisers, antipsychotics, anticonvulsants, and stimulants.
Sustained-release bupropion (150 mg/day for 1 week, followed by 200 mg/day for 3 weeks, 300 mg/day for 2 weeks then 400 mg); sertraline (50 mg/day for 2 weeks, …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.